Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Galena Biopharma (GALE) PT Cut to $4 at Maxim Group; 'Buy' Maintained
-
Pluristem Therapeutics (PSTI) PT Cut to $3 at Maxim Group; 'Buy' Maintained
-
Maxim Group Downgrades Cesca Therapeutics (KOOL) to Hold
-
Brainstorm Cell Therapeutics (BCLI) PT Cut to $5 at Maxim Group; 'Buy' Maintained
-
Capnia (CAPN) PT Trimmed to $3 at Maxim Group; 'Buy' Maintained after Granted Ophan Designation
-
Cytori Therapeutics (CYTX) Enters Agreements with Series A-1, A-2 Warrantholders; Updates on Cash Burn
-
Cytori Amends Corporate Warrant Agreements Simplifying Capital Structure and Updates on 2015 Operating Cash Burn Guidance
-
Maxim Group Starts Abeona Therapeutics (ABEO) at Buy
-
Maxim Group Starts Tristate Capital Holdings (TSC) at Buy
-
Maxim Group Starts ConnectOne Bankcorp (CNOB) at Buy
-
Maxim Group Starts Popeyes Louisiana Kitchen (PLKI) at Buy
-
Aeterna Zentaris (AEZS) Closes Common, Warrants Offering for Net Proceeds of ~$15M
-
Aeterna Zentaris Announces Closing of US$16.65 Million Public Offering of Common Shares and Warrants
-
X4 Pharmaceuticals Unveils Development Strategy for CXCR4 Inhibitor Pipeline in Cancer Supported by $37.5 million Series A Financing
-
Gladstone Land (LAND) Prices Reduced 900k Common Offering at $8.82/Share
-
Gladstone Land Corporation Announces Pricing of Common Stock Offering
-
Gladstone Land (LAND) to Offer 1.1M Shares of Common Stock
-
Gladstone Land (LAND) Announces 1.1M Common Stock Offering
-
Gladstone Land Corporation Announces Common Stock Offering
-
Gladstone Land Corporation Announces Common Stock Offering
-
Maxim Group Starts REEDS, Inc. (REED) at Buy
-
Aeterna Zentaris (AEZS) Prices Common Share/Warrant Offering at $5.55
-
Aeterna Zentaris Announces Pricing of US$16.65 Million Public Offering of Common Shares and Warrants
-
Workhorse Group Completes Private Placement of $13.5 Million in Convertible Notes With Warrants
-
Maxim Group Starts Cracker Barrel (CBRL) at Buy
-
Aeterna Zentaris (AEZS) to Offer Common Stock and Warrants
-
Aeterna Zentaris Announces Proposed Public Offering of Common Shares and Warrants
-
Norovirus suspected at Chipotle visited by 80 sick Boston College students
-
Maxim Group's Jason Kolbert and Jason McCarthy Interviewed by The Life Sciences Report
-
Maxim Group's Jason Kolbert and Jason McCarthy Interviewed by The Life Sciences Report
-
Prospect Capital Corporation Prices Public Offering of $150 Million of 6.25% Unsecured Notes Due 2024
-
Unusual 11 Mid-Day Movers 12/2: (ONDK) (MTSN) (ADMP) Higher; (ZFGN) (OGXI) (ATV) Lower
-
Anavex Life Sciences (AVXL) Latest Hire Seen as Important - Maxim Group
-
Cesca Therapeutics (KOOL) Has It All But Cash; Reiterated 'Buy' - Maxim Group
-
Kite Pharma (KITE) Bullish View Reiterated at Maxim Group Following Third Registraion Trial
-
ImmunoCellular (IMUC) Bullish View Reiterated at Maxim Group Amid ICT-107 Agreement
-
Celyad (CYAD) Bullish Stance Reiterated at Maxim Group as First Patient of Second Cohort Infused
-
Maxim Group Starts Adamis Pharmaceuticals (ADMP) at Buy
-
Maxim Group Positive on Anavex Life Sciences (AVXL) After Data Published in Respected Journal
-
The Joint Corp. (JYNT) Completes 2.27M Common Stock Follow-on Offering
-
The Joint Corp. Announces Closing of Follow-On Public Offering of Common Stock
-
The Joint Corp. Announces Closing of Follow-On Public Offering of Common Stock
-
Applied DNA Sciences (APDN) Closes 2.5M Share Registered Direct Offering
-
Applied DNA Sciences Announces Closing of $8.75 Million Registered Direct Offering
-
Maxim Group Reiterates Bullish View on Opexa Therapeutics (OPXA)
-
Notable Analyst Rating Changes 11/24: (EMES) (AVP) (QCOM) Upgraded; (GME) (BLOX) (ARP) Downgraded
-
UPDATE: Maxim Group Starts Stellar Biotechnologies (SBOT) at Buy
-
Maxim Group Starts Granite Construction (GVA) at Buy
-
Maxim Group Starts COPsync (COYN) at Buy
-
Notable Analyst Rating Changes 11/23: (CMG) (JRVR) (PBF) Upgraded; (TXTR) (CTCT) (CAVM) Downgraded


